Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer strikes deal with Atara Biotherapeutics to jointly work on CAR-T cell anti-tumour treatments

Ruchika Sharma9 Dec 2020 10:15 AM IST

Frankfurt: Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara's CAR-T cell anti-tumour treatments, as the German group...

Piramal Pharma invests over Rs 235 crore to expand Michigan facility

Ruchika Sharma8 Dec 2020 2:00 PM IST

New Delhi: Piramal Pharma Solutions on Tuesday said it is investing around USD 32 million (over Rs 235 crore) to expand its facility in Michigan, US,...

UK starts roll-out of Pfizer COVID-19 vaccine

Ruchika Sharma8 Dec 2020 12:00 PM IST

London: Britain will start rolling out the COVID-19 vaccine developed by Pfizer and BioNTech on Tuesday, the first Western country to start...

Healthtech Startup CURAPOD Raises Rs 20 Cr to Scale Wearable Pain Management Technology

Sinovac raises USD 500 million funding for COVID-19 Vaccine Development

Ruchika Sharma8 Dec 2020 10:00 AM IST

Beijing: Sinovac Biotech Ltd. has recently announced that Sinovac Life Sciences Co., Ltd., a subsidiary of Sinovac, has secured approximately US$500...

COVID-19: Antiviral drug Molnupiravir blocks virus transmission within 24 hours, claims Study

Ruchika Sharma7 Dec 2020 4:30 PM IST

"This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission. MK-4482/EIDD-2801 could be game-changing," said...

Zydus Cadila gets DCGI nod for Phase 1 trial of novel molecule ZYIL1

Ruchika Sharma7 Dec 2020 2:22 PM IST

New Delhi: Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...

Panacea Biotec eyes to ramp up vaccine, pharma verticals to steer long-term growth

Ruchika Sharma7 Dec 2020 1:00 PM IST

New Delhi: Panacea Biotec is looking to scale up its existing product portfolio, develop new medications and foray into new markets as part of its...

Pfizer seeks DCGI emergency use authorisation for COVID vaccine in India

Ruchika Sharma7 Dec 2020 12:58 PM IST

New Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use...

Sanofi to announce COVID vaccine price in development with GSK post Phase 1, 2 trial results

Ruchika Sharma7 Dec 2020 10:30 AM IST

Paris: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has...

Clinical trial participants paid over Rs 12 crore compensation in last 3 years for adverse events: DCGI

Ruchika Sharma6 Dec 2020 11:00 AM IST

Addressing a webinar, ''Regulatory Pathways for COVID19 Vaccines, Clinical trials, Rolling Reviews and Adverse Event Monitoring'', Drugs Controller...

BioNTech co-founder Ugur Sahin among world 500 richest people: Bloomberg

Ruchika Sharma6 Dec 2020 10:30 AM IST

New Delhi: Ugur Sahin just reached another milestone. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the...

Janssen Pharma seeks USFDA nod for Amivantamab for treating metastatic non-small cell lung cancer

Ruchika Sharma6 Dec 2020 10:00 AM IST

Raritan: The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S....

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok